Difference between revisions of "Part:BBa K3140000"
(41 intermediate revisions by the same user not shown) | |||
Line 3: | Line 3: | ||
<partinfo>BBa_K3140000 short</partinfo> | <partinfo>BBa_K3140000 short</partinfo> | ||
− | PsiD is a tryptophan decarboxylase | + | PsiD is a tryptophan decarboxylase that catalyses the conversion of L-tryptophan to tryptamine. |
*NCBI: [https://www.ncbi.nlm.nih.gov/protein/ASU62239.1 ASU62239.1] | *NCBI: [https://www.ncbi.nlm.nih.gov/protein/ASU62239.1 ASU62239.1] | ||
Line 11: | Line 11: | ||
===Usage and Biology=== | ===Usage and Biology=== | ||
− | + | The mechanism of psilocybin biosynthesis in ''Psilocybe'' sp. was recently elucidated by Fricke ''et al''.<ref name="Fricke">Fricke, J., Blei, F. & Hoffmeister, D. Enzymatic Synthesis of Psilocybin. ''Angew Chem Int Ed Engl'' '''56''', 12352-12355 (2017).</ref>, demonstrating that L-tryptophan proceeds through decarboxylation (mediated by PsiD), hydroxylation (mediated by PsiH), phosphorylation (mediated by PsiK), and finally N,N-dimethylation (mediated by PsiM) to yield psilocybin. | |
− | + | PsiD is a native enzyme obtained from the ''Psilocybe cubensis'', which is involved in the metabolic biosynthesis of psilocybin from tryptophan. It accepts both L-tryptophan and 4-hydroxy-L-tryptophan as substrates, producing tryptamine ('''Fig. 1''') and 4-hydroxytryptamine ('''Fig. 2'''), respectively. In a native state, PsiD is a 439 amino acid protein (49.6 kDa) with a theoretical pI of 5.44 calculated with the ExPASy ProtParam tool<ref name="ExPASy">Artimo, P. et al. ExPASy: SIB bioinformatics resource portal. ''Nucleic Acids Res'' '''40''', W597-603 (2012).</ref>. | |
− | [[Image:T--Sydney_Australia--PsiD_KEGG_rxn1.gif| | + | [[Image:T--Sydney_Australia--PsiD_KEGG_rxn1.gif|frame|none|'''Fig. 1''': Decarboxylation of L-tryptophan to tryptamine, mediated by PsiD. CO<sub>2</sub> is released as a by-product. Source: [https://www.genome.jp/dbget-bin/www_bget?reaction+R00685 KEGG] ]] |
− | [[Image:T--Sydney_Australia--PsiD_KEGG_rxn2.gif| | + | [[Image:T--Sydney_Australia--PsiD_KEGG_rxn2.gif|frame|none|'''Fig. 2''': Decarboxylation of 4-hydroxy-L-tryptophan to 4-hydroxytryptamine, mediated by PsiD. CO<sub>2</sub> is released as a by-product. Source: [https://www.genome.jp/dbget-bin/www_bget?reaction+R11932 KEGG] ]] |
− | + | Heterologous expression of PsiD has been achieved in a T7 induction system using pET-28c(+) transformed into ''Escherichia coli'' BL21(DE3), co-transformed with chaperone plasmid pGro7 ('''Fig. 3'''), resulting in a 475 amino acid polypeptide, with a computed molecular weight of 53.6 kDa. | |
− | [[Image:T--Sydney_Australia-- | + | [[Image:T--Sydney_Australia--PsiD_pET28c_map.png|700px|frame|none|'''Fig. 3''': pET-28c(+):PsiD plasmid map, showing C-terminal histidine tag, and T7 promoter under the control of the ''lac'' operator. Translated peptide is shown as the thin lime green arrow.]] |
+ | A band consistent with expression of PsiD in cells induced with IPTG was observed on polyacrylamide gel electrophoresis ('''Fig. 4'''). | ||
− | + | [[Image:T--Sydney Australia--SDS soluble PsiDKM.png|900px|thumb|none|'''Fig. 4''': Polyacrylamide gel electrophoresis image of soluble protein extract from uninduced and IPTG induced ''E. coli'' BL21(DE3)::pGro7 cells containing pET-28c(+):PsiD, pET-28c(+):PsiK, and pET-28c(+):PsiM, run on an Mini-PROTEAN® TGX Stain-Free™ precast gel (Bio-Rad) at 120V for 60 minutes.]] | |
− | + | ||
+ | Activity of PsiD was confirmed with LC/MS. Protein extract from ''E. coli'' BL21(DE3) cells co-transformed with pET-28c(+):PsiD and pGro7 was subject to LC/MS, both with and without the addition of the PsiD substrate, tryptophan. The PsiD product, tryptamine, was only identified in the sample to which tryptophan was added, confirming the activity of PsiD ''in vitro'' ('''Fig. 5'''). | ||
+ | |||
+ | [[Image:T--Sydney_Australia--PsiD%2Btryp_LCMS.png|frame|none|'''Fig. 5''': Mass spectra obtained LC/MS of protein extract of ''E. coli'' BL21(DE3) co-transformed with pET-28c(+):PsiD and pGro7, with the addition of tryptophan. A peak at m/z = 161.10732 with chemical formula C10H13N2 was identified, matching PsiD product tryptamine.]] | ||
+ | |||
+ | The presence of tryptophan in sample to which tryptophan was added may indicate autoxidation of tryptamine, as this compound was also observed in the mass spectrum of a 1 mM tryptamine standard ('''Table 1'''). However, neither hydroxytryptamine nor tryptamine was not observed in the sample to which tryptophan was not added ('''Table 2'''). | ||
+ | |||
+ | {| class="wikitable" | ||
+ | |+ ''Table 1'': Identified compounds in LC/MS of protein extract of ''E. coli'' BL21(DE3) co-transformed with pET-28c(+):PsiD and pGro7, with the addition of tryptophan. | ||
+ | |- | ||
+ | ! Retention time (min) | ||
+ | ! Signal/noise ratio | ||
+ | ! Measured m/z | ||
+ | ! Formula | ||
+ | ! Ion identity | ||
+ | |- | ||
+ | | 3.67 | ||
+ | | 5.3 | ||
+ | | 177.1023 | ||
+ | | C10H13N2O | ||
+ | | hydroxytryptamine | ||
+ | |- | ||
+ | | 4.91 | ||
+ | | 16.6 | ||
+ | | 205.0973 | ||
+ | | C11H13N2O2 | ||
+ | | tryptophan | ||
+ | |- | ||
+ | | 5.39 | ||
+ | | 17.8 | ||
+ | | 161.1074 | ||
+ | | C10H13N2 | ||
+ | | tryptamine | ||
+ | |- | ||
+ | | 10.12 | ||
+ | | 9.6 | ||
+ | | 285.1336 | ||
+ | | C14H21O6 | ||
+ | | unknown | ||
+ | |- | ||
+ | | 10.12 | ||
+ | | 9.6 | ||
+ | | 285.1336 | ||
+ | | C9H18N8OP | ||
+ | | unknown | ||
+ | |} | ||
+ | |||
+ | {| class="wikitable" | ||
+ | |+ ''Table 2'': Identified compounds in LC/MS of protein extract of ''E. coli'' BL21(DE3) co-transformed with pET-28c(+):PsiD and pGro7, without the addition of tryptophan. | ||
+ | |- | ||
+ | ! Retention time (min) | ||
+ | ! Signal/noise ratio | ||
+ | ! Measured m/z | ||
+ | ! Formula | ||
+ | ! Ion identity | ||
+ | |- | ||
+ | | 10.15 | ||
+ | | 10.3 | ||
+ | | 285.1336 | ||
+ | | C14H21O6 | ||
+ | | unknown | ||
+ | |- | ||
+ | | 10.15 | ||
+ | | 10.3 | ||
+ | | 285.1336 | ||
+ | | C9H18N8OP | ||
+ | | unknown | ||
+ | |} | ||
+ | |||
+ | ''In vivo'' expression of PsiD was also confirmed. PsiD, PsiK, and PsiM were cloned into a pUS250 backbone as a gene cluster using Golden Gate cloning, yielding pUS387 ('''Fig. 6'''). Expression in pUS387 is driven by a class 1 integron gene cassette Pc promoter controlled by a cumate induction system. ''E. coli'' DH5α cells co-transformed with pUS387 and pGro7 were cultured in terrific broth (TB) supplemented with 4-hydroxytryptamine. Whole cell culture was subject to LC/MS. | ||
+ | |||
+ | [[Image:T--Sydney_Australia--pUS387_map.png|700px|frame|none|'''Fig. 6''': pUS387 plasmid map, showing PsiD, PsiK, and PsiM genes organised in a cluster, driven by a class 1 integron gene cassette Pc promoter, flanked by CuO, a cumate repressor binding operator.]] | ||
+ | |||
+ | {| class="wikitable" | ||
+ | |+ ''Table 3'': Identified compounds in LC/MS of protein extract of ''E. coli'' DH5α co-transformed with pUS387 and pGro7, with the addition of 4-hydroxytryptamine. | ||
+ | |- | ||
+ | ! Retention time (min) | ||
+ | ! Signal/noise ratio | ||
+ | ! Measured m/z | ||
+ | ! Formula | ||
+ | ! Ion identity | ||
+ | |- | ||
+ | | 0.56 | ||
+ | | 23.2 | ||
+ | | 271.0817 | ||
+ | | C12H15O7 | ||
+ | | unknown | ||
+ | |- | ||
+ | | 1.16 | ||
+ | | 12.4 | ||
+ | | 257.0689 | ||
+ | | C10H14N2O4P | ||
+ | | norbaeocystin | ||
+ | |- | ||
+ | | 1.9 | ||
+ | | 0.9 | ||
+ | | 271.0844 | ||
+ | | C11H16N2O4P | ||
+ | | baeocystin | ||
+ | |- | ||
+ | | 2.75 | ||
+ | | 5.2 | ||
+ | | 177.1023 | ||
+ | | C10H13N2O | ||
+ | | hydroxytryptamine | ||
+ | |- | ||
+ | | 5.08 | ||
+ | | 6.4 | ||
+ | | 205.0972 | ||
+ | | C11H13N2O2 | ||
+ | | tryptophan | ||
+ | |- | ||
+ | | 5.82 | ||
+ | | 6.4 | ||
+ | | 161.1074 | ||
+ | | C10H13N2 | ||
+ | | tryptamine | ||
+ | |- | ||
+ | | 10.15 | ||
+ | | 14.4 | ||
+ | | 285.1335 | ||
+ | | C14H21O6 | ||
+ | | unknown | ||
+ | |- | ||
+ | | 10.15 | ||
+ | | 14.4 | ||
+ | | 285.1335 | ||
+ | | C9H18N8OP | ||
+ | | unknown | ||
+ | |} | ||
+ | |||
+ | The presence of tryptophan in LC/MS confirms the presence of endogenous tryptophan in ''E. coli''. As tryptophan was not added to these cultures, ''in vivo'' activity of PsiD is confirmed by observation of PsiD product tryptamine ('''Fig. 7'''). | ||
+ | |||
+ | [[Image:T--Sydney_Australia--tryptamine16_387_lcms.png|frame|none|'''Fig. 7''': Mass spectra obtained LC/MS of protein extract of ''E. coli'' DH5α co-transformed with pUS387 and pGro7, with the addition of 4-hydroxytryptamine. A peak at m/z = 161.10732 with chemical formula C10H13N2 was identified, matching PsiD product tryptamine.]] | ||
+ | |||
+ | Given these results, we conclude that we have successfully expressed the tryptophan decarboxylase PsiD from ''Psilocybe cubensis'' in ''Escherichia coli'' both ''in vivo'' and ''in vitro''. | ||
+ | |||
+ | <span class='h3bb'>'''Sequence and Features'''</span> | ||
+ | <partinfo>BBa_K3140000 SequenceAndFeatures</partinfo> | ||
<!-- Uncomment this to enable Functional Parameter display | <!-- Uncomment this to enable Functional Parameter display | ||
Line 32: | Line 170: | ||
<partinfo>BBa_K3140000 parameters</partinfo> | <partinfo>BBa_K3140000 parameters</partinfo> | ||
<!-- --> | <!-- --> | ||
+ | |||
+ | ===References=== |
Latest revision as of 08:45, 20 October 2019
PsiD - Tryptophan decarboxylase from Psilocybe cubensis
PsiD is a tryptophan decarboxylase that catalyses the conversion of L-tryptophan to tryptamine.
- NCBI: ASU62239.1
- UniProt: P0DPA6
- EC number: 4.1.1.105
Usage and Biology
The mechanism of psilocybin biosynthesis in Psilocybe sp. was recently elucidated by Fricke et al.[1], demonstrating that L-tryptophan proceeds through decarboxylation (mediated by PsiD), hydroxylation (mediated by PsiH), phosphorylation (mediated by PsiK), and finally N,N-dimethylation (mediated by PsiM) to yield psilocybin.
PsiD is a native enzyme obtained from the Psilocybe cubensis, which is involved in the metabolic biosynthesis of psilocybin from tryptophan. It accepts both L-tryptophan and 4-hydroxy-L-tryptophan as substrates, producing tryptamine (Fig. 1) and 4-hydroxytryptamine (Fig. 2), respectively. In a native state, PsiD is a 439 amino acid protein (49.6 kDa) with a theoretical pI of 5.44 calculated with the ExPASy ProtParam tool[2].
Heterologous expression of PsiD has been achieved in a T7 induction system using pET-28c(+) transformed into Escherichia coli BL21(DE3), co-transformed with chaperone plasmid pGro7 (Fig. 3), resulting in a 475 amino acid polypeptide, with a computed molecular weight of 53.6 kDa.
A band consistent with expression of PsiD in cells induced with IPTG was observed on polyacrylamide gel electrophoresis (Fig. 4).
Activity of PsiD was confirmed with LC/MS. Protein extract from E. coli BL21(DE3) cells co-transformed with pET-28c(+):PsiD and pGro7 was subject to LC/MS, both with and without the addition of the PsiD substrate, tryptophan. The PsiD product, tryptamine, was only identified in the sample to which tryptophan was added, confirming the activity of PsiD in vitro (Fig. 5).
The presence of tryptophan in sample to which tryptophan was added may indicate autoxidation of tryptamine, as this compound was also observed in the mass spectrum of a 1 mM tryptamine standard (Table 1). However, neither hydroxytryptamine nor tryptamine was not observed in the sample to which tryptophan was not added (Table 2).
Retention time (min) | Signal/noise ratio | Measured m/z | Formula | Ion identity |
---|---|---|---|---|
3.67 | 5.3 | 177.1023 | C10H13N2O | hydroxytryptamine |
4.91 | 16.6 | 205.0973 | C11H13N2O2 | tryptophan |
5.39 | 17.8 | 161.1074 | C10H13N2 | tryptamine |
10.12 | 9.6 | 285.1336 | C14H21O6 | unknown |
10.12 | 9.6 | 285.1336 | C9H18N8OP | unknown |
Retention time (min) | Signal/noise ratio | Measured m/z | Formula | Ion identity |
---|---|---|---|---|
10.15 | 10.3 | 285.1336 | C14H21O6 | unknown |
10.15 | 10.3 | 285.1336 | C9H18N8OP | unknown |
In vivo expression of PsiD was also confirmed. PsiD, PsiK, and PsiM were cloned into a pUS250 backbone as a gene cluster using Golden Gate cloning, yielding pUS387 (Fig. 6). Expression in pUS387 is driven by a class 1 integron gene cassette Pc promoter controlled by a cumate induction system. E. coli DH5α cells co-transformed with pUS387 and pGro7 were cultured in terrific broth (TB) supplemented with 4-hydroxytryptamine. Whole cell culture was subject to LC/MS.
Retention time (min) | Signal/noise ratio | Measured m/z | Formula | Ion identity |
---|---|---|---|---|
0.56 | 23.2 | 271.0817 | C12H15O7 | unknown |
1.16 | 12.4 | 257.0689 | C10H14N2O4P | norbaeocystin |
1.9 | 0.9 | 271.0844 | C11H16N2O4P | baeocystin |
2.75 | 5.2 | 177.1023 | C10H13N2O | hydroxytryptamine |
5.08 | 6.4 | 205.0972 | C11H13N2O2 | tryptophan |
5.82 | 6.4 | 161.1074 | C10H13N2 | tryptamine |
10.15 | 14.4 | 285.1335 | C14H21O6 | unknown |
10.15 | 14.4 | 285.1335 | C9H18N8OP | unknown |
The presence of tryptophan in LC/MS confirms the presence of endogenous tryptophan in E. coli. As tryptophan was not added to these cultures, in vivo activity of PsiD is confirmed by observation of PsiD product tryptamine (Fig. 7).
Given these results, we conclude that we have successfully expressed the tryptophan decarboxylase PsiD from Psilocybe cubensis in Escherichia coli both in vivo and in vitro.
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]